Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Using Index Level To Set Risk Tolerance helps you align your portfolio with your comfort and goals. Grasp practical steps to calibrate risk in real markets.
27,657 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
President Trump urged the Fed to cut rates immediately, sending ripples through cryptocurrency markets as traders pri...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
Payoneer’s quarterly results can illuminate how cross-border payments and freelance earnings ecosystems are evolving....
A top freestyle motocross rider weighs quitting after injuries and mounting costs, challenging whether high earnings ...
Private-market buyers are circling Anthropic as rumors of a massive follow-on round surface, pushing a volatile priva...
A Gambia-flagged cargo vessel attempting to enter an Iranian port was hit after ignoring numerous warnings, marking a...
The Defense Department expanded its 1260H roster to label Alibaba and Baidu as aiding the PLA, with BYD also targeted...
Pump.fun activity cratered over three months, pulling the PUMP token lower as traders pivot to Solana perpetual futur...
A major housing policy overhaul is poised to reshape mortgage lending as banks recalibrate underwriting and borrowers...
In this in-depth piece, we explore Mamoon Hamid’s approach to AI investing at Kleiner Perkins, the lessons from early...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...